MT2 Flashcards

1
Q

What are examples of Topical administrations that causes Localized Ocular Effects/Reactions?

A

Topical Steroids* - can cause catract/increase IOP
Topical Anti-glaucoma medications * - conjunctival changes
Ophthalmic ointments and gel * - temporary blur
Topical anesthetic drops for analgesia (relief of pain) - corneal epithelial cell loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ocular preservatives?

A

Causes localized ocular effects –> leads to superficial punctate keratitis (SPK)

Contact Sensitivity/Dermatitsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antibiotic Drug Classes:
Classes of Systemic Effect/Reactions

A
  • Penicillin (beta-lactam class)**
  • Cephalosporins (beta-lactam class) **
  • Sulfonamides (sulfa drugs)**
  • tetracycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Non- Antibiotic Drug Classes:
Classes of Systemic Effects/reactions

A

Anticonvulsants
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Allopurinol
Antihypertensives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CYP 450 Substrates

A

Anti-HIV Agents
Benzodiazepines **
Calcium Channel Blockers
Immunosuppressants **
Macrolide Antibiotics
Statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CYP 450 Inhibitors

A

Erythromycins
Grapefruit Juice
Antifungal Agents
Anti-HIV agents
Calcium channel blockers
Macrolide Antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CYP 450 Inducers

A

Antiepileptics
Anti-Seizure medications
Anti-HIV agents
Rifamycin
Anti-TB medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Three Main Categories of ADEs

A

Allergy or Drug Hypersensitivity reactions
Infection
Drug Toxicity: Ocular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the more severe drug-related skin reaction

A

Drug Induced Exfoliative dermatitis**
- stevens Johnson syndrome (SJS)*
- Toxic epidermal necrolysis (TEN)*
- Erythema Multiforme (less severe than SJS and TEN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)

A

*severe mucocutaneous reactions by medications
*Characterized by extensive epidermal necrosis and detachment of epidermis, sloughing of mucous membranes

signs: Hemorrhagic crusts on lips, extensive sloughing of epidermis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Erythema Multiforme (EM)

A

acute, immune mediated condition characterized by distinctive target-like lesions on skin

commonly induced by infection (herpes simplex virus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Difference between Minor vs Major Erythema Multiforme

A

Minor EM - without mucosal involvement

Major EM - with mucosal involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can Infection (ADEs) occur?

A

Contamination of the dropper or applicator tip – need to educate patients on sterile technique

dispose of expired/unused medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drug Toxicity: Ocular

A

SPK secondary to preservatives
SPK leads to Corneal inflammation, punctate corneal epithelial loss or damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Decisions for Healthcare Providers

A
  • Patient presentation: SIGN and SYMPTOMS
  • Knowledge of natural disease process
  • potential for morbidity: Risk Vs Benefit
  • ID any ocular or medical contraindications based on review of pt’s medical and medicine hx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Choice of Drug

A

Efficacy in relation to alternatives
- side effects (ADEs)
Drug Interactions
- Warnings or Precautions relative to co-morbidities/other diseases
- Compliance with dosage regiment
- Cost and insurance coverage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Communicating with Other providers of Care

A

SBAR
Situation, Background, Assessment, Recommendation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Baseline Measurements are taken PRIOR to administration of diagnostic or therapeutic ocular drugs

A

Biomicroscopy - topical anesthetics can compromise corneal epithelium & evaluation of aqueous and anterior chamber angle depth is ESSENTIAL before mydriatic agents

Tonometry - record IOP before mydriatics

Assess BP prior to administration of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Minimizing Systemic Adverse Drug Effects: General

A
  • systemic absorption with ocular administration is usually minimal
  • topically applied drugs avoid first pass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How would absorption into systemic circulation occur?
drugs enter into systemic circulation VIA blood vessels of :

A

*Conjunctival sac - conjuc. capillaries
*lacrimal drainage system - nasal mucosa –> oral pharynx –> GI tract
*Episclera (outermost layer of sclera) - via superficial and deep episcleral vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ways to REDUCE systemic absorption of topical applied drugs

A

Mechanical or Physical
- wiping excess* or manual nasolacrimal occlusion*

Prescribing Strategies
- use lowest conc.* and least number of doses per day* (MINIMIAL DOSAGE FREQ)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Ways to reduce Accidental Drug Exposure

A
  • store all medication out of reach of children
  • consider lockable medication storage areas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Percentage Solution

A

% weight/volume = # grams of solute in 100ml

1% = 1gm/100ml
0.5% = 0.5gm/100ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How many drops in 1 ml?

A

50microliter = 1gtt

**1ml = 20 drops (gtts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Warnings & Precautions: Systemic vs Ocular Administration
types of patients included under warnings and precautions! - Cardiac conditions - Pulmonary conditions - CNS conditions
24
Dangers of Atropine 1% - P.E.
Advise patients to store all medications out of reach of children - twenty drops (=10mg) may be fatal
25
Pharmacokinetics (review)
eyes have speical pharmacokinetics properties - what the body does to the drug - drugs are ADME- absorbed, distributed, metabolized, eliminated - - determines onset, intensity, and duration of drug action
26
Drug Absorption of Eye depends on
- Molecular properties of drug - viscosity of drug vehicle - function status of tissue (barrier to drug penetration)
27
What types of drugs have a better ability to pass through plasma membranes?
lipid-soluble drugs -- smaller molecular structure -- not ionized
28
Barriers of Eye : Static vs Dynamic
Static (like solids) - cornea, sclera, blood aqueous and blood- retinal barriers Dynamic (with movement) - choroidal and conjunctival blood flows, lymphatic clearance, and tear dilution
29
Prodrug (review)
inactive or weakly active substance that has an active metabolite. Requires Metabolic conversion to a pharmacologically active product Ex: Nepafenac (Nevanac and ilevro) - NSAID Ex: Clopidogrel (Plavix) Ex: Codeine
30
Drug metabolites may be inactive, less or more active than parent drug
*Metabolic enzymes are utilized in prodrug *Some drugs undergo biotransformation by enzymes in the eye to an inactive form associated with fewer side effects than parent form
31
Ocular Tissue Structure and Pharmacokinetics
avascularity at clear tissues of the eye, allows for direct route for ocular drug penetration via topical meds without high degree of absorption of systemic circulation
32
Tear Structure and Chemical Properties: tears are responsible for supply ________ to the ______ ___________
Tears are responsible for supplying Oxygen requirements of Corneal Epithelium
33
What are the layer of the tear film?
Oily Layer (Lipid) Center layer (Aqueous) Basal or Inner Layer (Mucinous)
34
Outermost Lipid Layer
- lipid monolayer, produced by meibomian glands - stabilizes surface to prevent evaporation
35
Aqueous Layer
- secreted by lacrimal glands - provides oxygen to corneal epithelium - antibacterial activity - wash away debris
36
Mucinous Layer
- composed of glycoproteins -- secreted by goblet cells - lubricates - permits wetting - thin hydrophilic coating - cleanses the tears of particulate debris
37
Tear Structure and Chemical Properties
tear pH = 7.4 (slightly basic) normal volume = 8-10 ml 1 drop of medication is 0.05ml, 5-6x the normal tear reservoir
38
Where does the excess drop of medication go?
*nasolacrimal duct rapidly drains the excess - some medication is blinked out of eye onto lid
39
Does increasing drop size increase penetration of medication into the cornea?
increasing drop size does NOT result in penetration of more medication into cornea - excess via nasolacrimal duct - spillage
40
What would be the impact of ocular irritation on absorption of ophthalmic medication?
conc. of drug available in the tears for transcorneal absorption is inversely proportional to the tear flow Increase tear flow = increase washout = decrease conc. Decrease tear flow = decrease washout = increase conc.
41
Concentration of drug available in tears for transcorneal absorption is inversely proportional to tear flow due to
- drug dilution* - drug removal by nasolacrimal duct* - eyelid spillover*
42
Dry Eye Patients: a decrease in tear flow rate will lead to -->
- lead to diagnosis of dry eye or keratoconjunctivitis sicca
43
Patient groups more susceptible to keratoconjunctivitis siccca*
- Elderly* - Rheumatoid arthritis* - Peri-menopausal and post-menopausal women* - exposure keratitis associated with dry climate*
44
Potential for increased drug absorption with lower tear flow rate
Total tear volume with less than normal volume may: - increased drug absorption --- as medication is not diluted well - prolonged residence time -- increase absorption - *presence of epithelial surface damage --> increase absorption
45
Corneal Layers
*Epithelium - Depot for lipophilic drugs Boman's Layer *Stroma - Depot for hydrophilic drugs, stores lipophilic drugs in keratocyes Descemet's Membrane Endothelium
46
Cornea
- major functional barrier to ocular penetration - Major site of absorption for topically applied medication
47
Corneal Nutrients
diffusion from aqueous humor for metabolic needs
48
What layer of the cornea have major influence on pharmacodynamics?
Epithelium and Stroma - constitutes depots/reservoirs for lipophilic and hydrophilic drugs
49
Corneal Epithelium
Surface Squamous Layer -- resists penetration of hydrophilic drugs Intermediate wing cells basal "germinative" layer - source of new cells (regenerates)
50
Surface Squamous Layer* -- resists penetration of hydrophilic drugs
- tight junctions or zona occludens * - lipid soluble drugs penetrate tight junctions due to phospholipid membrane - ionization decreases lipid solubility and increases water solubility ex: sodium fluorescein
51
What does a drug need to possess to effectively penetrate the cornea*** (transcorneal permeability)
drug must possess a BALANCE of hydrophilic and lipophilic properties - be able to partition between both media
52
Partition Coefficient
U- Shaped Parabola curve -- - drugs with too low a P.C (low transcorneal permeability) -- do not penetrate well - Drugs with a too high P.C. (high transcorneal permeability) -- tend to remain in epithelium and partition into anterior chamber slowly -
53
Bowman's Layer
- tough and provides substantial resistance to corneal injury/infection - cannot regenerate -- will scar if damage
54
Cornea Stroma - 90% thickness of cornea
- depots for hydrophilic drugs - stores lipophilic drugs in keratocytes - major determinant of corneal transparency - disruption of stroma --> potential scarring
54
Cornea Stroma - 90% thickness of cornea
- depots for hydrophilic drugs - stores lipophilic drugs in keratocytes - major determinant of corneal transparency - disruption of stroma --> some potential scarring, possible regeneration
55
Which layers are not known to be drug depots?
- Bowman's Layer - Descemet's Layer - Endothelium Layer
56
Corneal Sclera and Conjunctiva
have limited drug penetration -- less than 1/5 of all drug absorption - due to extensive vascularization
57
Iris
- pigmented tissue - Major function - adjust the amnt of light entering the retina - two groups of muscles - sphincter and ilator muscles
58
Sphincter/Circular Muscle
Cholinergic innervation - miosis - - innervation by sympathetic
59
Dilator/Radial Muscle
Adrenergic innervation - mydriasis - - innervation by parsympthetic
60
Aqueous Humor Flow and Angle
fluid generated from ciliary body exits via trabecular meshwork/conventional outflow
61
Ciliary Body
Produces aqueous humor by pigmented and nonpigmented ciliary epithelium *pigmented ciliary epithelium can store drugs - major ocular source of drug metabolizing enzymes** - important for Phase I CYP 450 Metabolism - detoxification -- via Phase II conjugation
62
Anterior Lens Epithelium
Most active metabolic region of lens * most prone to damage by drugs/toxic substances - major barrier for entry of hydrophilic, high molecular weight drugs - **lipophilic drugs can be absorbed slowly
63
Phase I Metabolism
- involve formation of new or modified functional group/cleavage - Oxidation, Hydrolysis, reduction - CYP450 enzyme is important -- located in liver endoplasmic reticulum
64
Phase II Metabolism
- glucuronic Acid conjugation - sulfate conjugation - glutathione conjugation
65
Lens associated with Cataracts
cataract formation can be increased by some miotics, *steroids, and phenothiazines
66
blood-retinal barrier of Retina and Optic Nerve
(tight junctional complexes/ zonula occludens) - prevents most hydrophilic drugs from penetrating or being absorbed from blood to retina and vitreous
67
Systemic Agents that cause Retinal Toxicity
* Hydroxychloroquine * sildenafil = phosphodiesterase inhibitor
68
Toxic Effects --> Optic Neuritis
* Phosphodiesterase inhibitors * amiodarone
69
Ocular Tissue: Removal of Drugs and Metabolites
- two different circulatory pathways in the eye - retinal vessels - uveal vessels - one non-circulatory pathway - direct outflow pathway
70
Retinal Blood Vessels (Circulatory Pathway)
removes drugs from vitreous humor and retina by ACTIVE transport
71
Uveal Blood vessels (circulatory pathway)
- removes drugs by BULK transport from iris and ciliary body (endocytosis/exocytosis) - requires energy
72
Direct Outflow Pathway (non-circulatory pathway)
- aqueous humor through trabecular meshwork and canal of schlem
73
Compartment Theory
- region of tissue or fluid which drugs can diffuse and equilibrate with relative ease - concentration gradients
74
Fick's Law of Diffusion
rate of diffusion across a barrier is proportional to the conc. gradient b/n compartments
75
Drug Diffusion of Cornea - Corneal Absorption
Factors that affect drug bioavailability - preservatives - infection - inflammation - neuronal control
76
First- Order Kinetics
More- common situation in ocular drug movements - rate of drug movement is proportional to conc difference - passive diffusion across non-saturated barrier
77
Zero- Order Kinetics
- release of drug is constant over time and is INDEPENDENT of conc. present - implantable device that releases drug at constant rate - ex: Fluocinolone (Iluvien and retisert) - ex: Dexamethasone (ozurdez) ^^ steroid ocular implants for diabetic macular edema